Phathom Pharmaceuticals Stock (NASDAQ: PHAT) stock price, news, charts, stock research, profile.
Open | $18.47 |
Close | - |
Volume / Avg. | 27.35K / 896.56K |
Day Range | $18.05 - $18.47 |
52 Wk Range | 6.07 - 19.71 |
Market Cap | $1.23B |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 58 |
Short Interest | 40.09% |
Days to Cover | 15.49 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of Phathom Pharmaceuticals (NASDAQ:PHAT) through any online brokerage.
Other companies in Phathom Pharmaceuticals’s space includes: Supernus Pharmaceuticals (NASDAQ:SUPN), WAVE Life Sciences (NASDAQ:WVE), Tarsus Pharmaceuticals (NASDAQ:TARS), Phibro Animal Health (NASDAQ:PAHC) and Rapport Therapeutics (NASDAQ:RAPP).
Phathom Pharmaceuticals has a consensus price target of $23.38.
The stock price for Phathom Pharmaceuticals (NASDAQ: PHAT) is $18.03 last updated September 23, 2024 at 9:54 AM EDT.
There are no upcoming dividends for Phathom Pharmaceuticals.
Phathom Pharmaceuticals’s Q3 earnings are confirmed for Thursday, November 7, 2024.
There is no upcoming split for Phathom Pharmaceuticals.
Phathom Pharmaceuticals is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.